Shanghai Synvida Biotechnology Co.,ltd.

This study is testing an experimental drug called SV001 in people with idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. The main goal is to check if the drug is safe and how the body processes it. Researchers will give the drug to 48 patients and compare them…

This is a very early study to check if a new drug called SV001 is safe for people. It will be given to 53 healthy Chinese adults to see how their bodies handle it. The drug is being developed to treat Idiopathic Pulmonary Fibrosis, a serious disease that causes permanent scarring…